SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Five pages from Marvel’s new Star Wars series shows Jedi badassery at its height
In these five unlettered pages from Star Wars: Jedi Knights #1, which Polygon can reveal courtesy of Marvel Comics, being ...
Long Island Press1d
Guggenheim Elementary guest speaker shares experiences in Africa
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
Time Out17d
All the art exhibits coming to NYC's Guggenheim Museum in 2025
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, you’ll find floor upon floor of artistic treasures. The modern and ...
Rubrik price target raised to $76 from $72 at Guggenheim
Guggenheim analyst John DiFucci raised the firm’s price target on Rubrik (RBRK) to $76 from $72 and keeps a Buy rating on the shares. The firm ...
Orphism, the early 20th century art movement, in focus at New York’s Guggenheim Museum
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
Morningstar1d
Guggenheim Macro Opportunities A
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...
Salesforce Stock’s AI Rally Is Over, Analyst Says. Why Now Could Be the Time to Sell.
Salesforce ended 2024 on a high note but fell on Monday after a Guggenheim analyst downgraded shares of the software company.